Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122988313 | 12298831 | 3 | F | 2015 | 20160906 | 20160425 | 20160919 | EXP | US-UCBSA-2016014235 | UCB | 60.00 | YR | M | Y | 91.00000 | KG | 20160919 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122988313 | 12298831 | 1 | PS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | Subcutaneous | 200 MG, EV 2 WEEKS(QOW) | 125160 | 200 | MG | QOW | |||||||
| 122988313 | 12298831 | 2 | C | METHOTREXATE. | METHOTREXATE | 1 | 20 MG, WEEKLY (QW), STARTED 20 YEARS AGO | 0 | 20 | MG | TABLET | /wk | |||||||
| 122988313 | 12298831 | 3 | C | METHOTREXATE. | METHOTREXATE | 1 | Oral | 10 MG, WEEKLY (QW) , 2.5 MG 4 TABLETS PER WEEK | 0 | 10 | MG | TABLET | /wk | ||||||
| 122988313 | 12298831 | 4 | C | Amlodipine/benazepril | AMLODIPINE BESYLATEBENAZEPRIL HYDROCHLORIDE | 1 | Oral | 5-10 MG DAILY STARTED 10-12 YEARS AGO | 0 | ||||||||||
| 122988313 | 12298831 | 5 | C | LIPOFEN | FENOFIBRATE | 1 | Oral | 150 MG DAILY STARTED 5 YEARS AGO | 0 | ||||||||||
| 122988313 | 12298831 | 6 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 2.5 MG DAILY ON AND OFF STARTED 21 YEARS AGO | 0 | ||||||||||
| 122988313 | 12298831 | 7 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Oral | 25 MG DAILY, STARTED 10 YEARS AGO | 0 | ||||||||||
| 122988313 | 12298831 | 8 | C | FOLIC ACID. | FOLIC ACID | 1 | Oral | 1 MG, 3X/WEEK, STARTED 6-8 MONTHS AGO | 0 | 1 | MG | TIW | |||||||
| 122988313 | 12298831 | 9 | C | LEUCOVORIN CALCIUM. | LEUCOVORIN CALCIUM | 1 | Oral | UNK, AS NEEDED (PRN) | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122988313 | 12298831 | 1 | Rheumatoid arthritis |
| 122988313 | 12298831 | 2 | Rheumatoid arthritis |
| 122988313 | 12298831 | 4 | Hypertension |
| 122988313 | 12298831 | 5 | Blood cholesterol increased |
| 122988313 | 12298831 | 6 | Rheumatoid arthritis |
| 122988313 | 12298831 | 7 | Blood pressure measurement |
| 122988313 | 12298831 | 8 | Unevaluable event |
| 122988313 | 12298831 | 9 | Nausea |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122988313 | 12298831 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122988313 | 12298831 | Colitis | |
| 122988313 | 12298831 | Gingivitis | |
| 122988313 | 12298831 | Herpes ophthalmic | |
| 122988313 | 12298831 | Infection | |
| 122988313 | 12298831 | Influenza | |
| 122988313 | 12298831 | Nausea | |
| 122988313 | 12298831 | Pneumonia | |
| 122988313 | 12298831 | Prostate infection | |
| 122988313 | 12298831 | Staphylococcal infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |